$Moderna, Inc.(MRNA)$ $Iovance Biotherapeutics, Inc.(IOVA)$ is sitting at only a 6.7 billion market cap with an FDA-approved product, while another company is at 86 billion without FDA approval for melanoma. Now there's positive lung data on top of that. Still about 80 billion to go for IOVA.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
